Embracing the Change: China Commercial Health Insurance Opportunities

Commercial health insurance (CHI) has an increasingly important role to play in China’s healthcare security system.

Why Consumers are Leaving your Website, and What to do About it

Apparel and footwear companies still have a long way to go to improve conversions.

Commercial Creativity for Industrials: Monetize to Make an Immediate Impact

For the past decade, technology and industrials companies have viewed digital through an “efficiency” lens.

True Profit! No Company Ever Went Broke Turning a Profit

Embracing the Change: Accessing Rare Disease Patients in China

Chinese rare diseases environments are dynamic and rapidly changing, and a number of new access and affordability options are emerging for innovative therapies.

A Day in the Life of Consultant Lillian in Beijing

Lillian Li, Consultant in our Beijing office, joined Simon-Kucher two years ago.

How digital health offerings can promote behavioral changes with effective UX design

In this article, we explore the active choices for UX design that contribute to the success of a digital health application and share three key pillars for success!

Patient Advocacy Groups – Key Support System When Planning the Launch of an Orphan Drug in Brazil

Patient advocacy groups (PAGs) for orphan diseases in Brazil (e.g., Instituto Vidas Raras, Casa Hunter) support manufacturers during all phases of launching an orphan drug.

New “Accord Cadre” finally released by the CEPS in France

The Accord Cadre is the framework agreement signed between the industry association of French pharmaceutical manufacturers (LEEM) and the CEPS (French pricing committee) that defines pricing regulation for both hospital and retail drugs.

What Will Be the Impact of the New IPT Consolidation Plan on P&MA in Spain?

In December 2020, the Spanish MoH presented a plan to consolidate Therapeutic Positioning Reports (IPTs) with an aim to formally incorporate health-economic evaluations into these reports (e.g. cost-effectiveness).